
Soy, Heart Health & Cholesterol
Coronary heart disease looms large over the U.S. with 13 million Americans having been diagnosed with coronary heart disease (CHD). Approximately one-half of men and one-third of women will develop CHD after age 40.1
While individual genetics play a role, four decades of rigorous investigation have proven the relationship between CHD and high cholesterol, a sedentary lifestyle, a high-fat diet, smoking and
obesity.2, 3 In fact, research published in 1990 showed that the proper diet along with other heart-healthy lifestyle changes can reduce severe coronary atherosclerosis.4
Soy foods can play an important role of the healthy diet that helps reduce cholesterol and fat in particular.5
There has been emphasis on reducing serum cholesterol levels, since elevated blood cholesterol is a well-established CHD risk factor. More than 100 million people age 20 or older — or more than half of this population — have cholesterol levels above the recommended target of 200 mg/dl. In fact, nearly 38 million Americans have cholesterol levels above 240 mg/dl, which puts them at high risk of developing heart disease.
Furthermore, over the past decade there has been a downward trend in the estimates of what is considered the ideal cholesterol level.
Although the current target goal for low-density-lipoprotein cholesterol (LDL) is <100 mg/dl, some data suggest that the ideal LDL level may be 50 to 70 mg/dl.6,7
Beyond elevated cholesterol there is evidence that diet favorably affects a number of risk factors for CHD, including elevated homocysteine levels,8 impaired vascular reactivity,9 decreased LDL particle size10 and hypertension.11
Soy Protein & Lowering Cholesterol
A substantial body of research – more than 80 human trials over the past 30 years – has been conducted investigating the effects of soy intake on cardiovascular health, with the general finding being that soy protein can help lower LDL (bad) cholesterol between at least 3 and 5 percent. Even these modest reductions have considerable relevance, since each 1 percent drop in LDL is associated with a 2 to 4 percent decrease in heart disease risk.12 13
The American Heart Association’s nutrition guidelines state that using soy protein as a replacement for animal protein products that are high in saturated fat may provide cholesterol-lowering benefits and that “the consumption of soy protein containing isoflavones, along with other heart-healthy diet modifications, is recommended for those high-risk populations with elevated total and LDL cholesterol.”14
In fact, in 1999 the Food and Drug Administration (FDA) issued the health claim that consuming 25 grams of soy protein per day, as part of a diet that is low in saturated fat and cholesterol, may reduce the risk of heart disease.
While soy is not medicine, it is a nutrient-rich food that can be an important part of a balanced diet. The degree of cholesterol reduction generally found with soy is comparable to that of other wholesome foods that carry an FDA heart-health claim, such as oatmeal. They are both foods that the FDA continues to advocate for use as part of a balanced diet to promote heart health. The hypocholesterolemic effects of soy protein began gaining widespread attention15 in 1995, when a meta-analysis by Anderson et al. proved that soy protein helped reduce serum cholesterol levels in 34 of 38 trials.16
Studies have shown that the reduction in cholesterol due to soy consumption is greater than that achievable on a low-saturated fat diet alone, since in most trials, subjects were on low-fat diets prior to participation in the trials. And, while soy protein alone may not lower cholesterol to a target goal in overtly hypercholesterolemic individuals, it can provide effects similar to that of soluble fiber.17
Most recently, the American Journal of Clinical Nutrition (AJCN) published a study18 that measured the effect of several soy protein sources vs. animal protein on many cardiovascular disease risk factors, including LDL cholesterol levels, by examining the effect of four diets (i.e., animal protein, whole soybeans, soy flour and soymilk). The study concluded that a diet of soymilk showed a significant reduction (4 percent) in LDL cholesterol compared to all other groups. The soymilk used in this experiment was Silk.
Eating Soy for Heart Health
In 1999, the U.S. Food and Drug Administration (FDA) approved a health claim for soy protein and coronary heart disease,19 and soon after the American Heart Association endorsed the use of soy foods for people with elevated cholesterol.20 Similar claims have been approved in the United Kingdom and the Philippines.
The FDA established 25 g/day of soy protein as the threshold amount required to lower cholesterol. Because the FDA assumed that it was reasonable to consume four servings of soy foods per day, products that provide at least 6.25 g soy protein per serving may carry the FDA health claim on their label. Some research shows that even smaller amounts of soy foods can also be efficacious.21-24
Anderson et al., in a new meta-analysis, recently concluded that dividing soy protein servings into multiple small servings is more effective in LDL reduction than the consumption of a single large serving.25
The Role of Soy Isoflavones
Science has not fully explained why general measures of heart health seem to improve when people eat soy foods. However, the isoflavones found in soy protein are thought to explain some of its impact.
Indirect support of this theory comes from a prospective epidemiologic study involving nearly 65,000 women in Shanghai, China. Even after controlling for a wide variety of risk factors, the study found that soy protein intake was associated with a marked reduction in the risk of non-fatal myocardial infarction (relative risk = 0.14 for the highest vs. the lowest quartile of intake; P for trend = 0.001), a protective effect far beyond that which could be expected from a modest reduction in cholesterol. Also of note: The fourth quartile soy protein intake cutoff in this study was only >11.19 g/day, far less the 25 g/day supported by the FDA.26
Soy may also favorably affect endothelial function.27 The endothelium, the thin layer of cells lining blood vessels, secretes several biologically active molecules (such as nitric oxide), which influences the health of the coronary vessels and, as a result, risk of heart disease.
Several studies, but by no means all, have shown that isoflavone-rich soy protein and isolated isoflavones increase arterial dilation in postmenopausal women – indicating improved enthothelial health.28-31
More speculative research suggests that soy lowers blood pressure,32, 33 improves systemic arterial compliance,34 inhibits LDL oxidation,35, 36 and reduces LDL particle size,37 making LDL less atherogenic.
Soy and Fatty Acid Content
Many soy foods, because of its relatively high polyunsaturated fat content (~25 percent of total energy), help lower serum cholesterol by displacing higher-saturated fats in the diet. 38, 39
The soy bean is one of the few good plant sources of the essential fatty acid, α-linolenic acid,40 an omega-3 fatty acid that has coronary benefits.41
A recent meta-analysis found that those subjects who consumed the most α-linolenic acid were approximately 20 percent less likely to die from CHD than those who ate the least α-linolenic acid.41 Importantly, the difference between the high- and low-consumers was only 1.2 g/day, the amount found in about 3 cups of full-fat soy milk.
Interestingly, one recent study found that soy oil, likely because of its α-linolenic acid content, was almost as effective as fish oil in increasing heart rate variability, which decreases risk of cardiac arrhythmia.42
Substantially reducing the risk of heart disease through lifestyle changes requires commitment. But it is clear that soy foods take an important lead in a heart-healthy diet.
Soy Fact
The cholesterol-lowering effects of soy protein were first demonstrated in animals in the 1940s and in humans in 1967. In 1977, researchers proved that soy protein accompanied major reductions in serum cholesterol in hypercholesterolemic patients.43-46
References
- American Heart Association. Heart Disease and Stroke Statistics -- 2005 Update. Dallas, Texas: American Heart Association; 2005.
- Blackburn H, Taylor HL, Keys A. Coronary heart disease in seven countries. XVI. The electrocardiogram in prediction of five-year coronary heart disease incidence among men aged forty through fifty-nine. Circulation 1970;41:I154-161.
- Keys A. A practical, palatable and prudent way of eating. J Med Assoc Ga 1970;59:355-359.
- Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336:129-133.
- Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Trautwein EA, Lapsley KG, Josse RG, Leiter LA, Singer W, Connelly PW. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 2005;81:380-387.
- O'Keefe JH, Jr., Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004;43:2142-2146.
- Cannon CP. The IDEAL cholesterol: lower is better. JAMA 2005;294:2492-2494.
- Graham I. Homocysteine in health and disease. Ann Intern Med 1999;131:387-388.
- Cuevas AM, Germain AM. Diet and endothelial function. Biol Res 2004;37:225-230.
- Desroches S, Lamarche B. Diet and low-density lipoprotein particle size. Curr Atheroscler Rep 2004;6:453-460.
- Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336:1117-1124.
- Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-372.
- Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ 1994;308:363-366.
- Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M; American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006 Feb 21;113(7):1034-44.
- Erdman JW, Jr. Control of serum lipids with soy protein. N Engl J Med 1995;333:313-315.
- Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-282.
- Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
- Mattan et al, Effect of soy protein from differently processed produects on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr, 2007: 85:960-6.
- Food and Drug Administration. Food labeling, health claims, soy protein, and coronary heart disease. Fed Reg 1999;57:699-733.
- Erdman JW, Jr. Soy protein and cardiovascular disease: A statement for healthcare professionals from the nutrition committee of the AHA. Circulation 2000;102:2555-2559.
- Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998;128:209-213.
- Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Jr., Hasler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000;71:1077-1084.
- Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002;76:78-84.
- Messina M. Potential public health implications of the hypocholesterolemic effects of soy protein. Nutr 2003;19:280-281.
- Anderson JW. Soy food effects on serum lipoprotein in humans: updated meta-analysis (abstract). Sixth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease (November; Chicago, IL) 2005.
- Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H, Jin F, Zheng W. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 2003;133:2874-2878.
- Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-175.
- Colacurci N, Chiantera A, Fornaro F, de Novellis V, Manzella D, Arciello A, Chiantera V, Improta L, Paolisso G. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 2005;12:299-307.
- Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, D'Anna R, Corrado F, Ruggeri P, Frisina N, Squadrito G. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003;114:470-476.
- Squadrito F, Altavilla D, Squadrito G, Saitta A, Cucinotta D, Minutoli L, Deodato B, Ferlito M, Campo GM, Bova A, Caputi AP. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 2000;45:454-462.
- Lissin LW, Oka R, Lakshmi S, Cooke JP. Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc Med 2004;9:26-30.
- He J, Gu D, Wu X, Chen J, Duan X, Whelton PK. Effect of soy bean protein on blood pressure: a randomized, controlled trial. Ann Intern Med 2005;143:1-9.
- Yang G, Shu XO, Jin F, Zhang X, Li HL, Li Q, Gao YT, Zheng W. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr 2005;81:1012-1017.
- Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-3398.
- Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, Sanders TA. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000;72:395-400.
- Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soy bean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A 1998;95:3106-3110.
- Desroches S, Mauger JF, Ausman LM, Lichtenstein AH, Lamarche B. Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic men and women. J Nutr 2004;134:574-579.
- Kris-Etherton PM. AHA science advisory: monounsaturated fatty acids and risk of cardiovascular disease. J Nutr 1999;129:2280-2284.
- Kris-Etherton PM, Krummel D, Russell ME, Dreon D, Mackey S, Borchers J, Wood PD. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc 1988;88:1373-1400.
- Wu Z, Rodgers RP, Marshall AG. Characterization of vegetable oils: detailed compositional fingerprints derived from electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. J Agric Food Chem 2004;52:5322-5328.
- Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004;134:919-922.
- Holguin F, Tellez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernandez M, Romieu I. Cardiac autonomic changes associated with fish oil vs. soy oil supplementation in the elderly. Chest 2005;127:1102-1107.
- Hodges RE, Krehl WA, Stone DB, Lopez A. Dietary carbohydrates and low cholesterol diets: effects on serum lipids on man. Am J Clin Nutr 1967;20:198-208.
- Meeker DR, Kesten HD. Experimental atherosclerosis and high protein diets. Proc Soc Exp Biol Med 1940;45:543-545.
- Meeker DR, Kesten D. Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol 1941;31:147-162.
- Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E. Soy bean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet 1977;1:275-277.
31. Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, D'Anna R, Corrado F, Ruggeri P, Frisina N, Squadrito G. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003;114:470-476.
32. Squadrito F, Altavilla D, Squadrito G, Saitta A, Cucinotta D, Minutoli L, Deodato B, Ferlito M, Campo GM, Bova A, Caputi AP. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 2000;45:454-462.
33. Lissin LW, Oka R, Lakshmi S, Cooke JP. Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc Med 2004;9:26-30.
22. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Jr., Hasler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000;71:1077-1084.
23. Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002;76:78-84.
24. Messina M. Potential public health implications of the hypocholesterolemic effects of soy protein. Nutr 2003;19:280-281.
29. Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, D'Anna R, Corrado F, Ruggeri P, Frisina N, Squadrito G. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003;114:470-476.
30. Squadrito F, Altavilla D, Squadrito G, Saitta A, Cucinotta D, Minutoli L, Deodato B, Ferlito M, Campo GM, Bova A, Caputi AP. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 2000;45:454-462.
31. Lissin LW, Oka R, Lakshmi S, Cooke JP. Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc Med 2004;9:26-30.
44. Meeker DR, Kesten HD. Experimental atherosclerosis and high protein diets. Proc Soc Exp Biol Med 1940;45:543-545.
45. Meeker DR, Kesten D. Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol 1941;31:147-162.
46. Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E. Soy bean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet 1977;1:275-277.
| Soy & Lower Cholesterol Eating Soy for Heart Health The Role of Soy Isoflavones Soy and Fatty Acid Content |
Soy Fact
![]() |
The cholesterol- lowering effects of soy protein were first demonstrated in animals in the 1940s and in humans in 1967. In 1977, researchers proved that soy protein accompanied major reductions in serum cholesterol in hypercholesterolemic patients.45-48 |

